Page 525 - IJB-9-6
P. 525

International Journal of Bioprinting                         Advances for 3D-printed oral drug delivery systems




            3D Printer Prusa i3MK3, and had different formulations.    (ii)  Quality assurance is one of the main concerns
            The blind-watermarking bits were printed as a pattern on   of developing 3D-printed oral DDS due to the
            the flat sides of the oblong tablets; the bits were distributed   regulatory challenges. The QbD approach is being
            across the layers, and the interaction between the layers   used  to improve  efficiency  in  the design of  a
            created a code. Even though this is a novel approach,   product, by identifying the parameter effects with
            not all polymers are suitable for this method, and QR   the selected responses. Tools like DoE, ANOVA,
            codes can store more information than bits encoded in    and Box–Behnken design are implemented to
            the tablet [104] .                                      ensure quality. At the same time, protocols to
                                                                    standardize compounding procedures (mixing,
            3.4.4. Mobile health technologies                       preparation, and printing) as well as decision maps
            Smartphone-enabled 3D printers can be an innovative     to facilitate decision-making are being developed.
            option to patients that have non-complex dosage         The integration of all these methods can lead to
            formulations; they can be located at the patient’s home,   quality assurance in the different types of dosage
            and given their accessibility, they can be printed at    forms.
            any moment.                                         (iii)  Trends related to the final end-user application

               Xu et al. created a smartphone-enabled 3D printer for   included  abuse-deterrent  3D-printed  oral
            dosage forms. The compact printer used the light from the   dosage forms that are being designed to limit
            smartphone to photopolymerize liquid resins and created   the  accessibility to non-prescribed opioids,
            solid structures, and it worked under stereolithography   as a solution to the global opioid abuse crisis.
            principles. Warfarin printlets were produced based on the   3D-printed pediatric formulations taking into
            shape determined on the smartphone app. The printlets   consideration the age, maximum daily dose,
            obtained high resolutions and outstanding dimensional   route of administration, and toxicity of the active
            precision. The developed printer can be an alternative   ingredients are also being developed. Tailored
            to produce tablets in resource-limited settings, in     3D-printed pediatric oral dosage forms are an
            emergencies, or at the patient’s home [105] .           opportunity to adapt  formulations  that  are  not
                                                                    commercially available for children. For disease
            4. Conclusion                                           treatment, 3D-printed capsules that allow the intake
                                                                    of multiple drugs and avoid negative interactions
            According to the main objective of this research, a CTI   between active pharmaceutical ingredients are also
            methodology was applied to analyze 3D-printed oral DDS,   being studied.
            specifically to reveal the current trends and advances in
            R&D in terms of end-user applications, quality assurance,    (iv)  For user acceptability, 3D-printed oral DDS
            user acceptability, and digital technologies. The research   have a general positive impact on children,
            period was from January 1, 1900, to May 1, 2023. Some of   healthcare professionals, and general patients, and
            the most important insights are:                        understanding the user preferences can facilitate
                                                                    the emergence of these types of dosage forms in the
              (i)  There  is  a  tendency  toward  digitalization  in  the   market. Aside from the processes, materials, and
                 industry that foresees the migration of clinical trials   functionality of these dosage forms, researchers
                 to digital solutions. Machine learning is being used   are now taking into consideration the physical
                 to optimize and predict process parameters and     appearance and taste to increase their appeal, making
                 formulation behaviors, with some of the optimized   them more user-centered.
                 models already available for general use, which is the
                 case  of  M3DISEEN,  a  web-application  predicting   The results of this study can be helpful for researchers,
                 tool based on artificial intelligence. Applications like   organizations, and investment firms interested in novel
                 DEFEND3D are being assessed to avoid cyber risks   treatments, R&D in areas of 3D printing, medicine,
                 stemming from the remote digital transfer of electronic   healthcare, and pharmaceutics.
                 prescriptions to the 3D printer. Digital technologies are
                 also used as facilitators; QR codes are being tested as   Acknowledgments
                 a traceability method to increase security and obtain   The  authors  acknowledge  the  institutional  support
                 additional information about the dosage form. Light   received from Tecnologico de Monterrey and the National
                 from smartphones was used to enable 3D printing of   Council of Humanities, Science and Technology of Mexico
                 dosage forms on a medium-sized 3D printer.    (CONAHCYT).



            Volume 9 Issue 6 (2023)                        517                          https://doi.org/10.36922/ijb.1119
   520   521   522   523   524   525   526   527   528   529   530